Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 2.1 Exhibit 2.1
- 2.2 Exhibit 2.2
- 2.3 Exhibit 2.3
- 3.1 Exhibit 3.1
- 4.1 Exhibit 4.1
- 10.1 Exhibit 10.1
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 23.4 Exhibit 23.4
- 23.5 Exhibit 23.5
GLMD similar filings
Filing view
External links
Exhibit 23.4
CONSENT OF NOMINEE FOR DIRECTOR
I hereby consent to being named as a person who will become a director of Galmed Pharmaceuticals Ltd., an Israeli company (the “Company”), in the Registration Statement on Form F-1 filed by the Company with the Securities and Exchange Commission (as amended from time to time, the “Registration Statement”), to the disclosure under the caption "Management" in the Registration Statement and to the filing of this consent as an exhibit to the Registration Statement.
Date: February 6, 2014
/s/ Tali Yaron-Eldar | |
Tali Yaron-Eldar |